CA2105913A1 - Adsorbate of an auxiliary mixture and a non-solid active compound for the preparation of pharmaceutical compositions - Google Patents

Adsorbate of an auxiliary mixture and a non-solid active compound for the preparation of pharmaceutical compositions

Info

Publication number
CA2105913A1
CA2105913A1 CA002105913A CA2105913A CA2105913A1 CA 2105913 A1 CA2105913 A1 CA 2105913A1 CA 002105913 A CA002105913 A CA 002105913A CA 2105913 A CA2105913 A CA 2105913A CA 2105913 A1 CA2105913 A1 CA 2105913A1
Authority
CA
Canada
Prior art keywords
adsorbate
active compound
preparation
mixture
hoe
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002105913A
Other languages
English (en)
French (fr)
Inventor
Theophil Hornykiewytsch
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hoechst AG
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2105913A1 publication Critical patent/CA2105913A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/143—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Pyridine Compounds (AREA)
CA002105913A 1992-09-11 1993-09-10 Adsorbate of an auxiliary mixture and a non-solid active compound for the preparation of pharmaceutical compositions Abandoned CA2105913A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4230371 1992-09-11
DEP4230371.0 1992-09-11

Publications (1)

Publication Number Publication Date
CA2105913A1 true CA2105913A1 (en) 1994-03-12

Family

ID=6467712

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002105913A Abandoned CA2105913A1 (en) 1992-09-11 1993-09-10 Adsorbate of an auxiliary mixture and a non-solid active compound for the preparation of pharmaceutical compositions

Country Status (13)

Country Link
EP (1) EP0587137A1 (enrdf_load_stackoverflow)
JP (1) JPH06192093A (enrdf_load_stackoverflow)
KR (1) KR940006583A (enrdf_load_stackoverflow)
AU (1) AU663000B2 (enrdf_load_stackoverflow)
CA (1) CA2105913A1 (enrdf_load_stackoverflow)
FI (1) FI933954A7 (enrdf_load_stackoverflow)
HU (1) HUT67577A (enrdf_load_stackoverflow)
IL (1) IL106953A0 (enrdf_load_stackoverflow)
MX (1) MX9305578A (enrdf_load_stackoverflow)
NO (1) NO933237L (enrdf_load_stackoverflow)
NZ (1) NZ248627A (enrdf_load_stackoverflow)
TW (1) TW222585B (enrdf_load_stackoverflow)
ZA (1) ZA936695B (enrdf_load_stackoverflow)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2160368A1 (en) * 1993-06-04 1994-12-22 Stanley J. Lech Preparations containing silicon dioxide to improve the taste thereof
US5626878A (en) * 1995-01-10 1997-05-06 Warner Lambert Company Reduction of electrostatic forces between magnesium trisilicate adsorbates
ATE254907T1 (de) * 1998-12-18 2003-12-15 Abbott Lab Natriumhydrogendivalproat-formulierungen mit gesteuerter freigabe
CN101001613B (zh) * 2004-06-28 2010-09-29 生命周期药物公司 作为液体制剂载体的多孔片剂

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2879161A (en) * 1956-05-14 1959-03-24 American Cyanamid Co Stable dry powder compositions containing choline chloride and methods of preparing same
DE3409063A1 (de) * 1984-03-13 1985-09-19 Basf Ag, 6700 Ludwigshafen Verfahren zur herstellung von fliessfaehigen cholinchlorid-kieselsaeure-pulvern
DE3924093A1 (de) * 1989-07-20 1991-02-07 Hoechst Ag N,n'-bis(alkoxy-alkyl)-pyridin-2,4-dicarbonsaeurediamide, verfahren zu deren herstellung sowie deren verwendung
DE4020570A1 (de) * 1990-06-28 1992-01-02 Hoechst Ag 2,4- und 2,5-substituierte pyridin-n-oxide, verfahren zu deren herstellung sowie deren verwendung
GB9025251D0 (en) * 1990-11-20 1991-01-02 Solomon Montague C Nifedipine dosage forms

Also Published As

Publication number Publication date
NO933237D0 (no) 1993-09-10
FI933954A0 (fi) 1993-09-09
HUT67577A (en) 1995-04-28
JPH06192093A (ja) 1994-07-12
NZ248627A (en) 1995-01-27
FI933954L (fi) 1994-03-12
EP0587137A1 (de) 1994-03-16
AU4626293A (en) 1994-03-17
IL106953A0 (en) 1993-12-28
MX9305578A (es) 1994-03-31
NO933237L (no) 1994-03-14
FI933954A7 (fi) 1994-03-12
HU9302555D0 (en) 1993-11-29
KR940006583A (ko) 1994-04-25
TW222585B (enrdf_load_stackoverflow) 1994-04-21
ZA936695B (en) 1994-04-05
AU663000B2 (en) 1995-09-21

Similar Documents

Publication Publication Date Title
CA2012194A1 (en) Solid pharmaceutical composition containing nifedipine
KR920006909B1 (ko) 니트렌디핀을 함유하는 고상 약제의 제조 방법
US5464612A (en) Solid preparation comprising ion exchanger and active agent
EP0159852A2 (en) Directly compressible pharmaceutical compositions
WO2002017921A2 (en) Paroxetine compositions and processes for making the same
KR0177493B1 (ko) 단사정계 결정구조를 갖고 감열, 감광 및 감습성이 있는 활성성분을 함유하는 정제의 제조방법
CA2744211A1 (en) Wet granulation of tenofovir, emtricitabine and efavirenz
EP1976522A1 (en) Pharmaceutical composition containing montelukast
JP4387192B2 (ja) Ｓ−アデノシルメチオニンを含む錠剤の調製方法
JPS62242616A (ja) ロキソプロフエン・ナトリウム含有製剤
JPS58109412A (ja) ニフエジピン固形製剤
CA2105913A1 (en) Adsorbate of an auxiliary mixture and a non-solid active compound for the preparation of pharmaceutical compositions
CA2363376A1 (en) Solid pharmaceutical compositions for oral administration comprising itraconazole
JPS5883617A (ja) ジヒドロピリジンを含有する固体の迅速放出性薬剤調製物及びその製造方法
JP2009091362A (ja) 高含量ファムシクロビル錠剤
JP2689458B2 (ja) 粒状ないし粉末状のビタミンｂ▲下１▼▲下２▼類含有組成物
EP1292598B1 (en) Process for drying amoxicillin
CZ20032828A3 (en) A stable pharmaceutical composition of pravastatin
JP2669517B2 (ja) ロキソプロフェン・ナトリウム含有固形製剤
KR20040073501A (ko) 신속 방출 활성 물질을 함유하는 초순도 플루다라 경구제제
JP2000239185A (ja) 医薬組成物
SK11098A3 (en) Process for preparing solid dosage forms of very low-dose drugs
RU2183119C1 (ru) Фармацевтическая композиция, обладающая спазмолитической активностью, способ ее получения
CA2280925A1 (en) Stabilized cefuroxime axetil
JPH037645B2 (enrdf_load_stackoverflow)

Legal Events

Date Code Title Description
FZDE Discontinued